Laboratoire de Chimie de Coordination UPR 8241


Accueil

Francoise BENOIT-VICAL
DR
0561175823
IPBS A-1B

Publications


2022

Egwu, C. O., Pério, P., Augereau, J. - M., Tsamesidis, I., Benoit-Vical, F., & Reybier, K. (2022). Resistance to artemisinin in falciparum malaria parasites: A redox-mediated phenomenon. Free Radical Biol. Med., 179, 317–327.
Paloque, L., Coppée, R., Stokes, B. H., Gnädig, N. F., Niaré, K., Augereau, J. - M., Fidock, D. A., Clain, J., & Benoit-Vical, F. (2022). Mutation in the Plasmodium falciparum BTB/POZ domain of K13 protein confers artemisinin resistance. Antimicrob. Agents Chemother., 66(1), e01320–21.
Tsamesidis, I., Mousavizadeh, F., Egwu, C. O., Amanatidou, D., Pantaleo, A., Benoit-Vical, F., Reybier, K., & Giannis, A. (2022). In vitro and in silico antimalarial evaluation of FM-AZ, a new artemisinin derivative. Medicines, 9(2), 8/1–12.

2021

Amrane, D., Arnold, C. - S., Hutter, S., Sanz-Serrano, J., Collia, M., Azqueta, A., Paloque, L., Cohen, A., Amanzougaghene, N., Tajeri, S., Franetich, J. - F., Mazier, D., Benoit-Vical, F., Verhaeghe, P., Azas, N., Vanelle, P., Botté, C., & Primas, N. (2021). 2-phenoxy-3-trichloromethylquinoxalines are antiplasmodial aerivatives with activity against the apicoplast of Plasmodium falciparum. Pharmaceuticals, 14(8), 724/1–24.
Bosson-Vanga, H., Primas, N., Franetich, J. - F., Lavazec, C., Gomez, L., Ashraf, K., Tefit, M., Soulard, V., Dereuddre-Bosquet, N., Le Grand, R., Donnette, M., Mustière, R., Amanzougaghene, N., Tajeri, S., Suzanne, P., Malzert-Fréon, A., Rault, S., Vanelle, P., Hutter, S., Cohen, A., Snounou, G., Roques, P., Azas, N., Lagardère, P., Lisowski, V., Masurier, N., Nguyen, M., Paloque, L., Benoit-Vical, F., Verhaeghe, P., et al. (2021). A new thienopyrimidinone chemotype shows multistage activity against Plasmodium falciparum, including artemisinin-resistant parasites. Microbiol. Spectrum, 9(2), e00274–21/1–19.
Egwu, C. O., Augereau, J. - M., Reybier, K., & Benoit-Vical, F. (2021). Reactive oxygen species as the brainbox in malaria treatment. Antioxidants, 10(12), 1872/1–20.
Egwu, C. O., Tsamesidis, I., Pério, P., Augereau, J. - M., Benoit-Vical, F., & Reybier, K. (2021). Superoxide: A major role in the mechanism of action of essential antimalarial drugs. Free Radical Biol. Med., 167, 271–275.
Ouji, M., Nguyen, M., Mustière, R., Jimenez, T., Augereau, J. - M., Benoit-Vical, F., & Deraeve, C. (2021). Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites. Bioorg. Med. Chem. Lett., 39, 127884/1–6.

2020

Ouji, M., Barnoin, G., Fernández Alvarez, A., Augereau, J. - M., Hemmert, C., Benoit-Vical, F., & Gornitzka, H. (2020). Hybrid gold(I) NHC-artemether complexes to target falciparum malaria parasites. Molecules, 25(12), 2817/1–20.
Ouji, M., Bourgeade Delmas, S., Fernandez Alvarez, A., Augereau, J. - M., Valentin, A., Hemmert, C., Gornitzka, H., & Benoit-Vical, F. (2020). Design, synthesis and efficacy of hybrid triclosan-gold based molecules on Artemisinin-resistant Plasmodium falciparum and Leishmania infantum parasites. ChemistrySelect, 5(2), 619–625.